HOME ABOUT US PRINT PUBLICATIONS SUBSCRIPTIONS CONTACT US TELL FRIEND RSS

Welcome to FDAweb Pay Per View Search our 45,610 - story database FREE   Free Items  Warning Letters  FDA Notices  FDA Calendar    FDA Whistleblowers          << Prev  5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 Next >>   FDA OKs R-Tech Ueno IND Severe Dry Eye Treatment [75 Words] [ Price : $7.95] FDA approves an IND application from R-Tech Ueno for Phase 1/2 trials of its RU-101 ophthalmic solution for treating dry eye. 04/26/2013     Hospira Recalls 1 Lot of Sodium Chloride [95 Words] [ Price : $7.95] Hospira recalls one lot of 0.9% sodium chloride injection, USP, 100 mL, flexible container after confirming a customer complaint involving particulate issues. 04/26/2013     Appeals Court Rules for Preemption in Generic Reglan Case [249 Words] [ Price : $7.95] Citing federal preemption grounds, an Iowa appeals court affirms several lower court decisions dismissing a failure-to-warn lawsuit by an injured plaintiff taking generic Reglan. 04/26/2013     FDA Warns on Bogus Botox [212 Words] [ Price : $7.95] An FDA drug safety alert warns about fraudulent versions of Allergan’s Botox being sold to U.S. medical practices. 04/26/2013     FDA Class 1 Recall for Infant Masks [94 Words] [ Price : $7.95] FDA classifies as Class 1 an Engineered Medical Systems recall of its SealFlex Single Port Ribbed Mask (Infant) due to mislabeling. 04/26/2013     Guidance on Pharmaceutical Co-Crystals [108 Words] [ Price : $7.95] Federal Register Notice: FDA releases a guidance, Regulatory Classification of Pharmaceutical Co-Crystals. 04/26/2013     Amphastar Whistleblower Complaint Against Aventis Moves On [323 Words] [ Price : $7.95] A California federal court says Amphastar’s whistleblower suit against Aventis alleging fraudulent Medicare and Medicaid claims for Lovenox may continue. 04/25/2013     Woodcock Urges Congress to Move Forward on Track-and-Trace [783 Words] [ Price : $7.95] CDER director Janet Woodcock urges Congress to come to terms on legislation to implement an effective national track-and-trace system for all drug products throughout the supply chain. 04/25/2013     Guidance on Assay Migration Studies for IVDs [84 Words] [ Price : $7.95] Federal Register Notice: FDA releases a guidance: Assay Migration Studies for In Vitro Diagnostic Devices. 04/25/2013     Actavis, Shire Reach Agreement on Generic Intuniv for ADHD [93 Words] [ Price : $7.95] Actavis Inc. and Shire reach an agreement to resolve patent litigation for Actavis’ generic version of Shire’s ADHD drug Intuniv. 04/25/2013     << Prev  5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24  Next >>

FERDIC INCORPORATED - P.O. Box 28, Camp Hill, PA 17001 | Phone: (717)731-1426 fax:(717)731-1427 Email: info@fdaweb.com